Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niven Mehra

Showing results (21-30 of 161) with videos related to

Pageof 17
Sort By:
Oncoimmunology|March 12, 2020
Lactate dehydrogenase: a marker of diminished antitumor immunitySandra Van Wilpe, Rutger Koornstra, Martijn Den Brok, et al.
Clinical Genitourinary Cancer|January 18, 2022
Evidence or Prejudice? Critical Re-Analysis of Randomized Controlled Trials Comparing Overall Survival After Cisplatin Versus Carboplatin-Based Regimens in Advanced Urothelial CarcinomaAnke Richters, Lambertus A L M Kiemeney, Niven Mehra, et al.
JCO Precision Oncology|January 20, 2022
Responsiveness to Immune Checkpoint Inhibitors Is Associated With a Peripheral Blood T-Cell Signature in Metastatic Castration-Resistant Prostate CancerDonjete Simnica, Minke Smits, Edith Willscher, et al.
Journal for Immunotherapy of Cancer|June 1, 2021
A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discoveryJeroen H A Creemers, W Joost Lesterhuis, Niven Mehra, et al.
Cancers|June 2, 2021
Homologous Recombination Repair Deficiency and Implications for Tumor ImmunogenicitySandra van Wilpe, Sofie H Tolmeijer, Rutger H T Koornstra, et al.
Cancers|September 24, 2020
Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the BladderSandra van Wilpe, Eveline C F Gerretsen, Antoine G van der Heijden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastasesNiven Mehra, Maarten Penning, Jolanda Maas, et al.
Oncology Reports|July 7, 2009
Identification of two new serum protein profiles for renal cell carcinomaJudith Y M N Engwegen, Niven Mehra, John B A G Haanen, et al.
JCO Clinical Cancer Informatics|January 23, 2026
Assessing the Detection Power of Genome-Wide Copy Number Variation Profiles in Prostate Cancer Using Simulated Shallow Whole-Genome Sequencing DataSamhita Pamidimarri Naga, Peter H J Slootbeek, Sofie H Tolmeijer, et al.
Clinical Nuclear Medicine|April 16, 2019
First Experience With 177Lu-PSMA-617 Therapy for Advanced Prostate Cancer in the NetherlandsLudwike van Kalmthout, Arthur Braat, Marnix Lam, et al.
Pageof 17

Showing results (21-30 of 161) with videos related to

Sort By:
Pageof 17
Oncoimmunology|March 12, 2020
Lactate dehydrogenase: a marker of diminished antitumor immunitySandra Van Wilpe, Rutger Koornstra, Martijn Den Brok, et al.
Clinical Genitourinary Cancer|January 18, 2022
Evidence or Prejudice? Critical Re-Analysis of Randomized Controlled Trials Comparing Overall Survival After Cisplatin Versus Carboplatin-Based Regimens in Advanced Urothelial CarcinomaAnke Richters, Lambertus A L M Kiemeney, Niven Mehra, et al.
JCO Precision Oncology|January 20, 2022
Responsiveness to Immune Checkpoint Inhibitors Is Associated With a Peripheral Blood T-Cell Signature in Metastatic Castration-Resistant Prostate CancerDonjete Simnica, Minke Smits, Edith Willscher, et al.
Journal for Immunotherapy of Cancer|June 1, 2021
A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discoveryJeroen H A Creemers, W Joost Lesterhuis, Niven Mehra, et al.
Cancers|June 2, 2021
Homologous Recombination Repair Deficiency and Implications for Tumor ImmunogenicitySandra van Wilpe, Sofie H Tolmeijer, Rutger H T Koornstra, et al.
Cancers|September 24, 2020
Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the BladderSandra van Wilpe, Eveline C F Gerretsen, Antoine G van der Heijden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastasesNiven Mehra, Maarten Penning, Jolanda Maas, et al.
Oncology Reports|July 7, 2009
Identification of two new serum protein profiles for renal cell carcinomaJudith Y M N Engwegen, Niven Mehra, John B A G Haanen, et al.
JCO Clinical Cancer Informatics|January 23, 2026
Assessing the Detection Power of Genome-Wide Copy Number Variation Profiles in Prostate Cancer Using Simulated Shallow Whole-Genome Sequencing DataSamhita Pamidimarri Naga, Peter H J Slootbeek, Sofie H Tolmeijer, et al.
Clinical Nuclear Medicine|April 16, 2019
First Experience With 177Lu-PSMA-617 Therapy for Advanced Prostate Cancer in the NetherlandsLudwike van Kalmthout, Arthur Braat, Marnix Lam, et al.
Pageof 17